Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer’s Disease

by | Aug 31, 2026 | Clinical Trials | 0 comments

​ Conditions: Preclinical Alzheimer’s Disease

Interventions: Drug: Obicetrapib 10 mg; Drug: Matching placebo tablets

Sponsors: NewAmsterdam Pharma

Not yet recruiting Conditions: Preclinical Alzheimer’s Disease
Interventions: Drug: Obicetrapib 10 mg; Drug: Matching placebo tablets
Sponsors: NewAmsterdam Pharma
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *